Action Revance Therapeutics - RVNC

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

3,65

Prix Achat

3,84

Prix Vente

3,10

Volume échangé

0,00 Fourchette du Jour 0,00

2,30 Plage de 52 semaines 6,65

Clôture Veille

3,65

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

1 720 710

Volume financier

VWAP

Form 15-12G - Securities registration termination [Section 12(g)]

Investors in Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC

Investors in Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your...

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	3.65	3.65	3.65	0	0	CS
4	0	0	3.65	3.65	3.65	0	0	CS
12	0.57	18.5064935065	3.08	3.7	3.03	1720710	3.43364425	CS
26	-2.92	-44.4444444444	6.57	6.59	3.01	2568273	4.38380361	CS
52	-2.65	-42.0634920635	6.3	6.65	2.3	2733204	4.7114846	CS
156	-12.88	-77.9189352692	16.53	37.98	2.3	1846758	12.19829081	CS
260	-15.9	-81.3299232737	19.55	37.98	2.3	1354483	13.96706843	CS

RVNC - Frequently Asked Questions (FAQ)

What is the current Revance Therapeutics share price?

The current share price of Revance Therapeutics is US$ 3,65

What is the 1 year trading range for Revance Therapeutics share price?

Revance Therapeutics has traded in the range of US$ 2,30 to US$ 6,65 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
AWHAspira Womans Health Inc	US$ 0,3512 (77,37%)	96,56M
TSVT2seventy bio Inc	US$ 4,93 (76,07%)	3,29M
SNOASonoma Pharmaceuticals Inc	US$ 4,34 (55,56%)	25,6M
ONDSOndas Holdings Inc	US$ 1,0999 (51,29%)	7,11M
SYRSSyros Pharmaceuticals Inc	US$ 0,137 (49,56%)	85,16M
MBXMBX Biosciences Inc	US$ 5,01 (-44,21%)	2
ARVNArvinas Inc	US$ 11,01 (-37,30%)	709,04k
XAGELongevity Health Holdings Inc	US$ 0,2375 (-25,78%)	1,02M
SNCRSynchronoss Technologies Inc	US$ 6,01 (-22,45%)	4
SPGCSacks Parente Golf Inc	US$ 0,1243 (-22,36%)	5,25M
AWHAspira Womans Health Inc	US$ 0,3512 (77,37%)	96,56M
SYRSSyros Pharmaceuticals Inc	US$ 0,137 (49,56%)	85,16M
CUTRCutera Inc	US$ 0,1784 (38,83%)	59,29M
BHATBlue Hat Interactive Entertainment Technology	US$ 0,04 (19,40%)	40,56M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 7,49 (1,49%)	34,98M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Revance Therapeutics Inc (RVNC)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

RVNC Dernières nouvelles

Form 15-12G - Securities registration termination [Section 12(g)]

Investors in Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form 15-12G - Securities registration termination [Section 12(g)]

Investors in Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

RVNC - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Revance Therapeutics Inc (RVNC) Cours

Revance Therapeutics Inc (RVNC)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

RVNC Dernières nouvelles

Form 15-12G - Securities registration termination [Section 12(g)]

Investors in Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form 15-12G - Securities registration termination [Section 12(g)]

Investors in Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

RVNC - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités